A survey of the anti-apoptotic Bcl-2 subfamily expression in cancer types provides a platform to predict the efficacy of Bcl-2 antagonists in cancer therapy.

Source:http://linkedlifedata.com/resource/pubmed/id/21364647

Download in:

View as

General Info

PMID
21364647